Impact of Valve Size on Paravalvular Leak and Valve Hemodynamics in Patients With Borderline Size Aortic Valve Annulus.
borderline aortic annulus
multi-detector computed tomography
paravalvular leak
transcatheter aortic valve implantation
valve hemodynamics
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
01
01
2022
accepted:
01
02
2022
entrez:
31
3
2022
pubmed:
1
4
2022
medline:
1
4
2022
Statut:
epublish
Résumé
Transcatheter heart valve (THV) selection for transcatheter aortic valve implantation (TAVI) is crucial to achieve procedural success. Borderline aortic annulus size (BAAS), which allows a choice between two consecutive valve sizes, is a common challenge during device selection. In the present study, we evaluated TAVI outcomes in patients with BAAS according to THV size selection. We performed a retrospective study including patients with severe aortic stenosis (AS) and BAAS, measured by multi-detector computed tomography (MDCT), undergoing TAVI with self-expandable (SE) or balloon-expandable (BE) THV from the Israeli multi-center TAVI registry. The aim was to evaluate outcomes of TAVI, mainly paravalvular leak (PVL) and valve hemodynamics, in patients with BAAS (based on MDCT) according to THV sizing selection in between 2 valve sizes. In addition, to investigate the benefit of shifting between different THV types (BE and SE) to avoid valve size selection in BAAS. Out of 2,352 patients with MDCT measurements, 598 patients with BAAS as defined for at least one THV type were included in the study. In BAAS patients treated with SE-THV, larger THV selection was associated with lower rate of PVL, compared to smaller THV (45.3 vs. 64.5%; pv = 0.0038). Regarding BE-THV, larger valve selection was associated with lower post-procedural transvalvular gradients compared to smaller THV (mean gradient: 9.9 ± 3.7 vs. 12.5 ± 7.2 mmHg; BAAS is common among patients undergoing TAVI. Selection of a larger THV in these patients is associated with lower rates of PVL and optimized THV hemodynamics with no effect on procedural complications. Additionally, shift from borderline THV to non-borderline THV modified both THV hemodynamics and post-dilatation rates.
Sections du résumé
Background
UNASSIGNED
Transcatheter heart valve (THV) selection for transcatheter aortic valve implantation (TAVI) is crucial to achieve procedural success. Borderline aortic annulus size (BAAS), which allows a choice between two consecutive valve sizes, is a common challenge during device selection. In the present study, we evaluated TAVI outcomes in patients with BAAS according to THV size selection.
Methods
UNASSIGNED
We performed a retrospective study including patients with severe aortic stenosis (AS) and BAAS, measured by multi-detector computed tomography (MDCT), undergoing TAVI with self-expandable (SE) or balloon-expandable (BE) THV from the Israeli multi-center TAVI registry. The aim was to evaluate outcomes of TAVI, mainly paravalvular leak (PVL) and valve hemodynamics, in patients with BAAS (based on MDCT) according to THV sizing selection in between 2 valve sizes. In addition, to investigate the benefit of shifting between different THV types (BE and SE) to avoid valve size selection in BAAS.
Results
UNASSIGNED
Out of 2,352 patients with MDCT measurements, 598 patients with BAAS as defined for at least one THV type were included in the study. In BAAS patients treated with SE-THV, larger THV selection was associated with lower rate of PVL, compared to smaller THV (45.3 vs. 64.5%; pv = 0.0038). Regarding BE-THV, larger valve selection was associated with lower post-procedural transvalvular gradients compared to smaller THV (mean gradient: 9.9 ± 3.7 vs. 12.5 ± 7.2 mmHg;
Conclusion
UNASSIGNED
BAAS is common among patients undergoing TAVI. Selection of a larger THV in these patients is associated with lower rates of PVL and optimized THV hemodynamics with no effect on procedural complications. Additionally, shift from borderline THV to non-borderline THV modified both THV hemodynamics and post-dilatation rates.
Identifiants
pubmed: 35355970
doi: 10.3389/fcvm.2022.847259
pmc: PMC8959481
doi:
Types de publication
Journal Article
Langues
eng
Pagination
847259Informations de copyright
Copyright © 2022 Talmor-Barkan, Kornowski, Bar, Ben-Shoshan, Vaknin-Assa, Hamdan, Kruchin, Barbash, Danenberg, Perlman, Konigstein, Finkelstein, Steinvil, Merdler, Segev, Barsheshet and Codner.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
N Engl J Med. 2016 Apr 28;374(17):1609-20
pubmed: 27040324
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
Circ Cardiovasc Interv. 2020 Jul;13(7):e008714
pubmed: 32646304
N Engl J Med. 2012 May 3;366(18):1686-95
pubmed: 22443479
Eur Heart J. 2017 Sep 21;38(36):2717-2726
pubmed: 28605423
J Am Coll Cardiol. 2017 Aug 15;70(7):845-853
pubmed: 28797353
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):1-9
pubmed: 25616813
Eur Heart J. 2015 Feb 14;36(7):449-56
pubmed: 25273886
Eur Heart J. 2012 Oct;33(19):2403-18
pubmed: 23026477
Circ Cardiovasc Interv. 2016 Jul;9(7):
pubmed: 27369803
Interv Cardiol. 2020 Jul 29;15:e11
pubmed: 32905123
JACC Cardiovasc Interv. 2020 May 11;13(9):1071-1082
pubmed: 32305398
J Am Coll Cardiol. 2012 Apr 3;59(14):1287-94
pubmed: 22365423
JACC Cardiovasc Interv. 2018 Jan 22;11(2):160-168
pubmed: 29348010
Lancet. 2006 Sep 16;368(9540):1005-11
pubmed: 16980116
JACC Cardiovasc Imaging. 2019 Jan;12(1):1-24
pubmed: 30621986
Circulation. 2020 Jan 28;141(4):243-259
pubmed: 31736356
JACC Cardiovasc Interv. 2021 Oct 11;14(19):2158-2169
pubmed: 34620395